Target (CBDY) Current Deferred Revenue (2019 - 2026)

Target (CBDY) reported Current Deferred Revenue of $285540.0 for Q1 2026, up 44.54% quarter-over-quarter from $197557.0 in Q4 2025.

Target (CBDY) Current Deferred Revenue (2019 - 2026) Analysis & Trends

Target (CBDY) has 7 years of Current Deferred Revenue data on file, last reported at $285540.0 in Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $285540.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $285540.0 (changed N/A YoY), and the FY2025 annual result was $197557.0, changed N/A from the prior year.
  • Current Deferred Revenue improved to $285540.0 in Q1 2026 per CBDY's latest filing, from $197557.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $285540.0 in Q1 2026 and troughed at $41644.0 in Q2 2024.
  • A 4-year average of $108033.0 and a median of $43098.0 in 2023 frame the typical range for Current Deferred Revenue.
  • On a YoY basis, Current Deferred Revenue climbed as much as 146.53% in 2025 and fell as far as 146.53% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $43098.0 in 2023, then decreased by 2.02% to $42226.0 in 2024, then surged by 367.86% to $197557.0 in 2025, then soared by 44.54% to $285540.0 in 2026.
  • Business Quant data shows CBDY's Current Deferred Revenue at $285540.0 in Q1 2026, $197557.0 in Q4 2025, and $104100.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 285,540.00
Dec 31, 2025 197,557.00
Sep 30, 2025 104,100.00
Sep 30, 2024 42,226.00
Jun 30, 2024 41,644.00
Mar 31, 2024 42,066.00
Dec 31, 2023 43,098.00
Mar 31, 2021 27,500.00
Dec 31, 2020 42,719.00
Sep 30, 2020 42,719.00
Mar 31, 2020 42,719.00
Dec 31, 2019 262,199.00
Sep 30, 2019 128,158.00
Jun 30, 2019 342,642.00
Mar 31, 2019 334,346.00